1. Home
  2. SUNS vs ONCY Comparison

SUNS vs ONCY Comparison

Compare SUNS & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$7.19

Market Cap

108.7M

Sector

Real Estate

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.68

Market Cap

109.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
ONCY
Founded
2023
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Pharmaceuticals and Biotechnology
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.7M
109.1M
IPO Year
2024
2002

Fundamental Metrics

Financial Performance
Metric
SUNS
ONCY
Price
$7.19
$0.68
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
★ $8.75
$7.33
AVG Volume (30 Days)
63.2K
★ 944.2K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
★ 16.17%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.54
N/A
Revenue
★ $21,571,434.00
N/A
Revenue This Year
$70.81
N/A
Revenue Next Year
N/A
$2,505.00
P/E Ratio
$13.39
★ N/A
Revenue Growth
★ 102.96
N/A
52 Week Low
$7.16
$0.64
52 Week High
$11.06
$1.51

Technical Indicators

Market Signals
Indicator
SUNS
ONCY
Relative Strength Index (RSI) 38.54 30.96
Support Level N/A N/A
Resistance Level $8.11 $1.06
Average True Range (ATR) 0.23 0.05
MACD -0.00 -0.01
Stochastic Oscillator 4.55 18.78

Price Performance

Historical Comparison
SUNS
ONCY

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: